Philadelphia, PA
Adverse events are the pillars of pharmacovigilance and safety operations as we know them. They are the drivers for developing safety databases, risk management plans, risk evaluation and mitigation strategies, benefit-risk assessments, and periodic reports. Their collection and reporting is instrumental in leading to preventative actions for marketing better and safer drugs.
The 4th Adverse Event Reporting and Safety Strategies Summit illuminates and disseminates best practices in pharmacovigilance and adverse events management. Attendees will explore lessons learned and replicate best practices of our illustrious speaking faculty of regulators and industry-leading practitioners, and other experts.
The pharmacovigilance space is constantly evolving — as are the needs of professionals and stakeholders in this area. In order to promote patient safety, proactively monitor adverse events and understand their impact in every phase of development, it is crucial to keep up to date with the latest regulatory changes, innovations and emerging technologies.
This summit is expressly designed for PV professionals and stakeholders seeking to ensure global compliance and improve their company’s effectiveness in adverse events reporting, drug safety management and risk mitigation. The summit disseminates best practices of life sciences companies to detect and prevent adverse reactions that positively impact drug safety profiles by illuminating tactics for related to benefit-risk assessment, real-world data solutions and analyses, signal detection, periodic reporting and solicited/unsolicited reports.
